Publication: Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury
| dc.contributor.author | Erenler, Ali Kemal | |
| dc.contributor.author | Baydin, Ahmet | |
| dc.contributor.authorID | erenler, ali kemal/0000-0002-2101-8504 | |
| dc.date.accessioned | 2020-06-21T12:18:43Z | |
| dc.date.available | 2020-06-21T12:18:43Z | |
| dc.date.issued | 2020 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Erenler, Ali Kemal] Hitit Univ, Fac Med, Dept Emergency Med, Corum, Turkey -- [Baydin, Ahmet] Ondokuz Mayis Univ, Fac Med, Dept Emergency Med, Samsun, Turkey -- | en_US |
| dc.description.abstract | Interleukin-33 (IL-33) is a cytokine involved in interleukin-1 family. Role of IL-33 in immune system activation is well described in the literature. IL-33 has been identified as an endogenous alarm signal (alarmin) to alert various types of immune cells to trauma. In this narrative review, we aimed to underline the diagnostic and prognostic importance of IL-33 in trauma, particularly in brain trauma. | en_US |
| dc.identifier.doi | 10.1155/2020/1832345 | |
| dc.identifier.issn | 2090-2840 | |
| dc.identifier.issn | 2090-2859 | |
| dc.identifier.pmid | 32399302 | |
| dc.identifier.uri | https://doi.org/10.1155/2020/1832345 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10267 | |
| dc.identifier.volume | 2020 | en_US |
| dc.identifier.wos | WOS:000508441600001 | |
| dc.language.iso | en | en_US |
| dc.publisher | Hindawi Ltd | en_US |
| dc.relation.journal | Emergency Medicine International | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Interleukin-33 (IL-33) as a Diagnostic and Prognostic Factor in Traumatic Brain Injury | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication |
